Please sign in to follow a disease.

Elderly AML patients

Clinical trials for Elderly AML patients explained in plain language.

Never miss a new study

Get alerted when new Elderly AML patients trials appear

Sign up with your email to follow new studies for Elderly AML patients, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Department of hematology, the second affiliated hospital of kunming medical university.

Completed

Combining the results of previous studies and based on the clinical practice in our center, we designed the Venetoclax in combination with 3days-Decitabine regimen for induction therapy in elderly or unfit AML patients with a primary diagnosis, and set Venetoclax in combination w…

Matched conditions: ELDERLY AML PATIENTS

Phase 3 • Sponsor: The Second Affiliated Hospital of Kunming Medical University

Last updated Sep 09, 2026 16:00 UTC

Elderly AML patients

Get alerted when new Elderly AML patients trials appear

Department of hematology, the second affiliated hospital of kunming medical university.